Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Alimentary Pharmacology & Therapeutics
|
September 5, 2014
End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndrome
M F Dawwas, G P Aithal
Gut
|
September 13, 2006
Guidelines on the management of ascites in cirrhosis
K P Moore, G P Aithal
The American Journal of Gastroenterology
|
November 28, 2001
Steering azathioprine safely: lessons from pharmacogenetics
G P Aithal, B J Hoffman
Alimentary Pharmacology & Therapeutics
|
July 27, 2001
Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment
G P Aithal, J C Mansfield
The British Journal of Dermatology
|
December 20, 2014
The quest for an evidence-based approach to surveillance for methotrexate-related hepatotoxicity: promise and perils
M F Dawwas, G P Aithal
The New England Journal of Medicine
|
July 14, 2001
High serum IgG4 concentrations in patients with sclerosing pancreatitis
G P Aithal, N P Breslin, B Gumustop
Journal of Hepatology
|
December 29, 2000
Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions
G P Aithal, M D Rawlins, C P Day
Journal of the Royal Society of Medicine
|
September 2, 2003
A not-so-simple collapse
E Raw, L Hudsmith, G P Aithal, et al.
BMJ (Clinical Research Ed.)
|
December 11, 1999
Accuracy of hepatic adverse drug reaction reporting in one English health region
G P Aithal, M D Rawlins, C P Day
Lancet (London, England)
|
June 7, 2000
Is clinical examination an art?
G P Aithal, R N Harrison, P D Snashall
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Alimentary Pharmacology & Therapeutics
|
September 5, 2014
End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndrome
M F Dawwas, G P Aithal
Gut
|
September 13, 2006
Guidelines on the management of ascites in cirrhosis
K P Moore, G P Aithal
The American Journal of Gastroenterology
|
November 28, 2001
Steering azathioprine safely: lessons from pharmacogenetics
G P Aithal, B J Hoffman
Alimentary Pharmacology & Therapeutics
|
July 27, 2001
Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment
G P Aithal, J C Mansfield
The British Journal of Dermatology
|
December 20, 2014
The quest for an evidence-based approach to surveillance for methotrexate-related hepatotoxicity: promise and perils
M F Dawwas, G P Aithal
The New England Journal of Medicine
|
July 14, 2001
High serum IgG4 concentrations in patients with sclerosing pancreatitis
G P Aithal, N P Breslin, B Gumustop
Journal of Hepatology
|
December 29, 2000
Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions
G P Aithal, M D Rawlins, C P Day
Journal of the Royal Society of Medicine
|
September 2, 2003
A not-so-simple collapse
E Raw, L Hudsmith, G P Aithal, et al.
BMJ (Clinical Research Ed.)
|
December 11, 1999
Accuracy of hepatic adverse drug reaction reporting in one English health region
G P Aithal, M D Rawlins, C P Day
Lancet (London, England)
|
June 7, 2000
Is clinical examination an art?
G P Aithal, R N Harrison, P D Snashall
Page
of 6